MedTrace Logo

The Medacta International GMK Sphere Post-Marketing Surveillance Study

NCT02199600 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2024-12-16

No results posted yet for this study

Summary

This is a Post-Marketing Surveillance of GMK Sphere knee prosthesis.

Conditions

Interventions

DEVICE

GMK Sphere Knee Replacement

Sponsors & Collaborators

  • Medacta International SA

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2029-10-31
Completion
2029-10-31

Countries

  • Belgium
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02199600 on ClinicalTrials.gov